Delivery Order SPE2DB25D3504-SPE2DB25FVVEK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), effective August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this delivery order at its corporate office location....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,339.62 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, was competitively awarded with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,041.64 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-pack quantity) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,038.24 on August 19, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-pack units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by August 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child transaction...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,633.36 for Xulane 150-35 mcg/day transdermal patches (3-count) on June 24, 2025, with an ultimate completion date of June 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award conditions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,322.95 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count supply) with a firm fixed price arrangement. This order was competitively awarded without set-aside designation and is scheduled for completion on September 16, 2025, one day after the award date of September 15, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,776.65 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This competitively awarded, firm fixed-price contract was issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The award utilizes no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at approximately $23.8k to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price, competitively awarded delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,136.91 for Xulane 150-35 mcg/day contraceptive patches (3-count units) on July 2, 2025, with an ultimate completion date of July 3, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,945.86 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (3-count units), with an ultimate completion date of July 21, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its Corporate Office location. This award represents a single transaction under the company's...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVEKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,610.48 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-unit supply) on June 20, 2025, with an ultimate completion date of June 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order is being fulfilled from the company's place of performance in Conshohocken. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling diverse medical supply needs through open competition, with awards encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 6/20/25 |